Subject: Cipher Pharmaceuticals (TSX: CPH) Update with CEO Craig Mull

Cipher Pharmaceuticals (TSX: CPH) Update with CEO Craig Mull
About Cipher Pharmaceuticals Inc.

Cipher Pharmaceuticals (TSX: CPH) is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products. Cipher acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and currently markets those products either directly in Canada or indirectly through partners in Canada, the U.S., and South America. For more information, visit www.cipherpharma.com.
After our interviews, we host a Free-For-All session with the live participants to review all things Smallcap Discoveries is following, including updates and commentary companies from both the Select Portfolio and Select Watchlist
86 East 23rd Ave, v5v 1w9, Vancouver, Canada
You may unsubscribe or change your contact details at any time.